Inactivated quadrivalent influenza vaccine

This page covers all Inactivated quadrivalent influenza vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Influenza hemagglutinin and neuraminidase antigens.

Targets

Influenza hemagglutinin and neuraminidase antigens

Marketed (2)

• VaxigripTetra™ by Sanofi, Inc. · Centers for Disease Control and Prevention · Immunology / Infectious Disease
  VaxigripTetra is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.
• FLUAD Quadrivalent · Centers for Disease Control and Prevention · Immunology / Infectious Disease
  FLUAD Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.

Phase 3 pipeline (4)

• Quadrivalent VLP Influenza Vaccine · Medicago · Immunology / Infectious Disease
  A plant-based virus-like particle (VLP) vaccine that presents influenza surface antigens to stimulate immune responses against four influenza virus strains.
• IL-YANG Quadrivalent Influenza Vaccine · Il-Yang Pharm. Co., Ltd. · Immunology / Infectious Disease
  IL-YANG Quadrivalent Influenza Vaccine stimulates the immune system to produce antibodies against four strains of influenza virus, providing protection against seasonal flu infection.
• FluLavalTM-VB · GlaxoSmithKline · Immunology / Infectious Disease
  FluLaval-VB is a quadrivalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus.
• Control Quadrivalent influenza virus vaccine · Sinovac Biotech Co., Ltd · Immunology
  This vaccine stimulates the immune system to produce antibodies and cellular immunity against four strains of influenza virus.

Patent intelligence

• quadrivalent influenza vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates